Hikma reiterates full year guidance following good start to the year
Riad Mishlawi, Hikma's CEO, said:
'We are pleased to reiterate our Group guidance for 2025. As a global company with strong local expertise and footprint, we are leveraging our manufacturing proficiency and advanced technologies to meet the needs of our customers and patients across our markets. Looking ahead, and recognising the broader geo-political challenges, we are well-positioned. Our step up in R&D investment, alongside local manufacturing enhancements, and strategic partnerships will continue to strengthen our portfolio and pipeline and ensure sustained success.'
Injectables
Our global Injectables business is delivering a solid revenue performance, driven by each of our three geographies. We are seeing strong demand for our products across our European and MENA markets, where we continue to launch new products. In North America we are benefitting from good demand for the recently launched liraglutide injection and the contribution from the newly acquired Xellia portfolio. This is helping to offset increased competition across some of our existing higher margin products.
We expect momentum to improve in the second half driven by new product launches and contract manufacturing. We are making excellent progress in the enhancements to our Bedford, Ohio facility, which will significantly increase our US-based injectables manufacturing capacity.
We continue to expect 2025 Injectables revenue to grow in the range of 7% to 9%. Phasing and mix of sales will impact margins in the first half but we continue to expect full year core operating margin to be in the mid-30s.
Branded
Our Branded business is performing well. We continue to make good progress in building our diversified portfolio of products used to treat chronic illnesses, with a focus on oncology and lifestyle diseases, supported by our global expertise and strong local market position.
Our leading presence in the MENA region, combined with the breadth of our reach and strong commercial capabilities positions us as a partner of choice. We recently signed an exclusive licensing agreement with pharmaand GmbH, a global pharmaceutical business based in Vienna, to commercialise rucaparib, an innovative small-molecule oral oncology therapy, across the MENA region. This is in line with our strategy to be a leading provider of oncology medicines in the region.
We continue to expect 2025 Branded revenue to grow in the range of 6% to 7% in constant currency, with core EBIT margin close to 25%.
Generics
In our Generics business we are seeing solid demand across our differentiated portfolio, particularly for our nasal and inhalation products. By focusing on reliability of supply, high service levels and leveraging our US manufacturing facility, we are successfully securing longer-term customer awards.
We continue to strengthen our R&D capabilities, including building a team in our new Zagreb, Croatia R&D centre, and are progressing with key development projects that will help strengthen our portfolio and pipeline for the medium to long-term. We are progressing well preparing our Columbus facility to accommodate our recently announced contract manufacturing partnership, and we are seeing increasing demand for our high-quality US-based manufacturing services.
We continue to expect Generics revenue to be broadly flat in 2025 with core operating margin of around 16%.
International trade policies
We are confident that our significant and expanding US manufacturing footprint, which supplies the majority of our US sales, combined with our focus on quality and reliability of supply, positions us well and underpins our resilience in the current environment. We do import some finished products into the US as well as capital equipment, and we have a diversified global supply chain for our raw and packaging materials, including active pharmaceutical ingredients (API).
Full year outlook unchanged
We continue to expect Group revenue to grow in the range of 4% to 6% and for core operating profit to be in the range of $730 million to $770 million in 2025. Group core operating profit growth, which is around 4% at the midpoint of guidance, will be weighted to the second half. We are monitoring the evolving tariff backdrop and will look to remain agile in responding to both opportunities and impacts where possible, but have not reflected an impact from tariffs in our full year outlook.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arabian Post
an hour ago
- Arabian Post
UAE's Amazon Bazaar Brings Budget Shopping to Mobile Shoppers
Arabian Post Staff -Dubai Amazon has unveiled a new mobile‑only shopping section called Bazaar within its Amazon. ae app in the UAE, delivering value‑focused products across fashion, home and lifestyle categories. Launching initially in beta for select users, the platform offers items priced mostly under AED 25, with some starting at just AED 4, alongside tiered savings, fast delivery, and a 15‑day returns policy. Stefano Martinelli, Vice‑President of Amazon MENA, said Bazaar is meant to be 'fun and effortless to browse', offering the trusted reliability of Amazon combined with surprising value. A launch‑month promotion grants shoppers a 25 per cent discount across all Bazaar purchases in July. ADVERTISEMENT Accessible via the 'Bazaar' icon in the Amazon. ae app or by searching 'Bazaar', the platform also supports browsing on mobile web at amazon. ae/bazaar. Desktop users must scan a QR code in the browser to open the feature within the app. Bazaar has its own search, cart and checkout system, distinct from the main Amazon experience. The interface is vibrant and purpose‑built for quick deal discovery. The platform integrates reviews and star ratings to aid user decisions. Delivery is standard across Amazon Bazaar accounts: orders above AED 90 qualify for free shipping and typically arrive within 6–12 days. Returns are free within 15 days for most products. Beyond initial price advantage, Bazaar encourages bulk purchases with automatic discounts: 5 per cent off orders over AED 150, and 10 per cent off for orders over AED 300. Combined with the launch‑month 25 per cent promotion, savings can accumulate significantly. In the UAE's booming e‑commerce environment—forecast to exceed US$ 13.8 billion by 2029—Bazaar positions Amazon to capture more bargain‑seeking consumers, complementing existing daily‑need offerings. Dharmesh Mehta, Vice‑President at Amazon, referred to the local variant as Amazon Bazaa r or 'Amazon Haul' as in other markets, noting its alignment with prior launches in the US, UK, Germany and Saudi Arabia. Gulf Business, Khaleej Times, What's On, Times of India and Arabian Business all report that Bazaar has launched in the UAE over the past week, emphasising its mobile‑first approach and bargain pricing. Analysts say the platform could strengthen Amazon's value proposition in the region and give competitors like Noon, Carrefour, and Mumzworld a run for their money in the low‑cost segment. Bazaar's playful app interface—especially its 'crazy‑low' deals and under‑AED 25 'super savers' sections—appeals to price‑sensitive shoppers.
%3Amax_bytes(150000)%3Astrip_icc()%2Fdogecoin-02b89237819544f19a7440c5405e12f7.jpg&w=3840&q=100)
Arabian Post
an hour ago
- Arabian Post
Stock market information for Dogecoin
Dogecoin is a crypto in the CRYPTO market. The price is 0.164341 USD currently with a change of -0.00 USD from the previous close. The intraday high is 0.167214 USD and the intraday low is 0.161817 USD. Memecoin Resilience: Dogecoin Holds Firm at $0.16 Level Dogecoin bounced off the $0.16 mark after a sharp intraday decline, signalling that bulls are defending this multi‑week floor. Trading volume surged near these levels, indicating accumulation and potential consolidation ahead. ADVERTISEMENT The memecoin dropped around 5 per cent intraday, bottoming at approximately $0.161 before recovering to about $0.163, according to CoinDesk's data. Volume during the bounce doubled the daily average, underscoring robust buyer interest around this critical price band. Market observers note that holding above $0.160 could pave the way for a sustained recovery. Technical analysts suggest Dogecoin may be forming a base around this level. CoinDesk's Shaurya Malwa points out that the token remained in a narrow range between $0.162 and $0.164 after the bounce—a pattern often associated with consolidation and trend reversals. The broader cryptocurrency landscape remains volatile. Macroeconomic pressures—particularly global trade tensions and central bank policy uncertainty—have triggered risk‑off sentiment. That volatility tends to amplify swings in meme‑style tokens like Dogecoin, yet it also creates value opportunities for strategic buyers. On‑chain interest appears healthy. Cryptocurrency analytics platform CoinGecko reports substantial trading activity across centralised exchanges, with 24‑hour turnover exceeding $900 million, although this reflects a slight dip from the previous week's average. Coinbase indicates Dogecoin remains the top memecoin by trading volume, commanding approximately 1 per cent of the total crypto market cap. In European trading on 3 July, Dogecoin climbed close to $0.174 following a defence of the $0.16 region. Analysts caution that this rebound, representing an 11 per cent gain from the low, may end up corrective rather than reflecting a confirmed trend shift. More Crypto Online, a technical analyst, contends the price movement fits an ABC diagonal wave pattern, warning that failure to hold $0.16 could invalidate bullish outlooks. Should the token maintain support, targets around $0.196 appear plausible; yet a break below $0.151 may trigger renewed weakness. Amid this backdrop, speculation builds around a possible Dogecoin‑based ETF. Amendments filed by Bitwise for a spot‑DOGE ETF have increased optimism, with analysts estimating a high probability of SEC approval by the year‑end. A green light could invite fresh institutional capital and broader market legitimacy, although timing expectations remain uncertain. Social media and celebrity influence continue to play a strong role. Elon Musk's intermittent endorsements and jovial online commentary have historically driven surges in trading volume and public interest. At present, Dogecoin remains range‑bound, with the $0.16 level acting as both a psychological and technical barrier. A sustained break above $0.164—coupled with upticks in volume—could signal a reversal toward mid‑$0.18 or even $0.20. Conversely, capitulation below the $0.16 threshold may re‑test June lows and weaken broader memecoin sentiment. Traders await forthcoming macroeconomic signals—US inflation data, central bank communications—and updates on ETF applications, all of which could determine whether Dogecoin's floor holds or fractures.
Arabian Post
an hour ago
- Arabian Post
Chip‑Scale Interconnect Boosted as Tenstorrent Acquires Blue Cheetah
Tenstorrent has acquired Blue Cheetah Analog Design, integrating the startup's expert team and chiplet interconnect IP into its in‑house capabilities, advancing its strategy for high‑performance AI hardware. The Canadian‑based AI chipmaker announced on 1 July 2025 that it has secured Blue Cheetah, a Sunnyvale‑headquartered innovator specialising in analog and mixed‑signal IP for chiplet designs. The move brings Blue Cheetah's BlueLynx die‑to‑die interconnect subsystem—compatible with Open Compute Project's Bunch of Wires and Universal Chiplet Interconnect Express standards—directly under Tenstorrent's control. Blue Cheetah, founded in 2018 and backed by Marvell luminaries Dr Sehat Sutardja and Weili Dai, has established a reputation for delivering customizable interconnect IP across various foundries and nodes. The startup's executive and engineering teams are led by co‑founder and CEO Dr Elad Alon, a recognised expert in analog/mixed‑signal design and technical lead for the Bunch of Wires PHY standard. ADVERTISEMENT According to Tenstorrent CEO Jim Keller, the acquisition will 'accelerate our chiplet vision of creating an open chiplet ecosystem, with open interconnects optimised for each specific chiplet socket'. Bringing critical analog capabilities in‑house is expected to enhance performance and efficiency in AI systems, especially as chiplet architectures gain prominence in scaling compute workloads. Dr Alon stated that Blue Cheetah had long collaborated with Tenstorrent as a customer and partner, and the merger will allow them to amplify their impact on chiplet ecosystems worldwide. This deal marks Tenstorrent's first semiconductor acquisition in the United States, and builds on its previous licensing agreement with Blue Cheetah for die‑to‑die interconnect technology in its AI and RISC‑V chiplet solutions. Analysts suggest that this vertical integration provides Tenstorrent with tighter control over its interconnect IP roadmap, reducing dependency on external vendors and improving time‑to‑market for future designs. Tenstorrent's global operations span offices in Austin, Silicon Valley, Toronto, Belgrade, Seoul, Tokyo and Bangalore, supported by investors including Eclipse Ventures, Samsung Catalyst Fund and Hyundai Motor Group. Blue Cheetah's integration deepens those ties, offering advanced analog interconnect capabilities critical to chiplet‑based AI and high‑performance computing platforms. Industry observers highlight the timing of the acquisition as significant. As demand grows for modular chiplet architectures—driven by the escalating compute requirements of AI workloads—having proprietary, standards‑compliant interconnect IP in‑house may enable Tenstorrent to lead in chiplet performance and ecosystem development. Their strategy aligns with Open Compute Project's push for interoperable chiplet interfaces, signalling potential influence on emerging chiplet standards. The hardware industry continues to shift from monolithic to chiplet‑driven designs, balancing energy efficiency, yield, and scalability. Tenstorrent's move mirrors broader efforts among AI‑hardware firms to secure key IP layers critical to end‑to‑end system performance. The Blue Cheetah team brings deep expertise in D2D, DDR, SerDes and physical‑link design—capabilities that are increasingly rare and valuable.' Dr Alon shared on LinkedIn that the integration of Blue Cheetah's team into Tenstorrent reflects a shared vision to 'build simple and comparable chiplet ecosystems,' noting the appreciation extended to partners, investors and employees as they embark on this 'tremendous impact' together.
